Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Camille Romero to attend Trilateral Technical Symposium on Strengthening Manufacturing Capacities to Respond to the Non-Communicable Diseases Burden

The Access to Medicine Foundation is co-organising a technical symposium with the World Health Organization (WHO) and the World Intellectual Property Organization (WIPO) at the World Trade Organization (WTO). Camille Romero, the Foundation’s Access to Medicine Research Programme Manager, will attend one of the sessions. In presenting the Foundation’s work, she will highlight key insights from the recently launched 2024 Index, with a focus on local manufacturing and licensing.

Date

13 December 2024

Location

Geneva, Switzerland

The Trilateral Symposium is the eleventh in a series of joint technical symposia on public health, intellectual property, and trade organized by WHO, WIPO, and the WTO. It builds on the agencies' collaborative efforts to strengthen Members’ capacity to address issues at the intersection of health, trade, and intellectual property. This year’s event, co-organised by the Foundation, focuses on the burden of non-communicable diseases (NCDs) and the promotion of innovation and access to health technologies for NCDs.

As a representative of the Foundation, Camille will participate in the second session of the event, titled “Coordinating Action through Local and Regional Manufacturing Capacity: Key Stakeholders, Challenges, and Opportunities.”  Drawing on key findings from the newly released 2024 Access to Medicine Index, she will discuss how companies are focusing on NCDs. Additionally, Camille will spotlight the progress made by pharmaceutical companies in local manufacturing and licensing of essential medicines, while also addressing areas that require improvement, particularly in underserved countries.

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Resource Centre

Read the key findings from 2024 Access to Medicine Index
Key findings

Pharma companies are taking steps to address access in low-income countries, but significant gaps remain

19 November 2024
Key findings

Patients in low- and middle-income countries largely left out of clinical trails, limiting access to new treatments

19 November 2024
Key findings

Efforts to ramp up wider local availability of medicines through voluntary licensing and technology transfers are limited

19 November 2024

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved